Quoin Historical Income Statement
| QNRX Stock | USD 0.62 0.02 3.13% |
Historical analysis of Quoin Pharmaceuticals income statement accounts such as Total Operating Expenses of 7 M, Net Interest Income of 647.5 K, Depreciation And Amortization of 96.1 K or Interest Expense of 0.0 can show how well Quoin Pharmaceuticals Ltd performed in making a profits. Evaluating Quoin Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Quoin Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Quoin Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Quoin Pharmaceuticals is a good buy for the upcoming year.
Quoin |
About Quoin Income Statement Analysis
Quoin Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Quoin Pharmaceuticals shareholders. The income statement also shows Quoin investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Quoin Pharmaceuticals Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Quoin Pharmaceuticals. It is also known as Quoin Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from Quoin Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Quoin Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quoin Pharmaceuticals Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Quoin Pharmaceuticals' Net Interest Income is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 726.5 K in 2024, whereas Selling General Administrative is likely to drop slightly above 4 M in 2024.
| 2023 | 2024 (projected) | Reconciled Depreciation | 119.6K | 96.1K | Cost Of Revenue | 103.4K | 102.9K |
Quoin Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Quoin Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Quoin Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Selling General Administrative | 1.5M | 1.4M | 4.5M | 6.6M | 6.1M | 4.0M | |
| Gross Profit | (227.1K) | (104.8K) | (104.1K) | (103.6K) | (103.4K) | (108.6K) | |
| Other Operating Expenses | 1.6M | 1.7M | 6.1M | 9.3M | 9.4M | 7.0M | |
| Operating Income | (1.6M) | (2.0M) | (20.4M) | (8.8M) | (9.4M) | (8.9M) | |
| Ebit | (1.6M) | (2.0M) | (20.4M) | (8.8M) | (9.4M) | (8.9M) | |
| Research Development | 45.7K | 244.2K | 1.6M | 2.7M | 3.3M | 3.0M | |
| Ebitda | (1.5M) | (1.9M) | (20.3M) | (8.7M) | (9.3M) | (8.8M) | |
| Total Operating Expenses | 1.6M | 1.7M | 6.1M | 9.3M | 9.4M | 7.0M | |
| Income Before Tax | (1.6M) | (2.1M) | (21.5M) | (9.4M) | (8.7M) | (8.3M) | |
| Net Income | (1.6M) | (1.8M) | (8.5M) | (9.3M) | (8.7M) | (8.3M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.